These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics]. Susić E Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687 [TBL] [Abstract][Full Text] [Related]
8. Extended-spectrum beta-lactamases: a challenge for clinical microbiologists and infection control specialists. Colodner R Am J Infect Control; 2005 Mar; 33(2):104-7. PubMed ID: 15761410 [TBL] [Abstract][Full Text] [Related]
9. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. Machado E; Coque TM; Cantón R; Novais A; Sousa JC; Baquero F; Peixe L; J Antimicrob Chemother; 2007 Dec; 60(6):1370-4. PubMed ID: 17913717 [TBL] [Abstract][Full Text] [Related]
10. [Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria]. Bayraktar B; Toksoy B; Bulut E Mikrobiyol Bul; 2010 Apr; 44(2):187-96. PubMed ID: 20549952 [TBL] [Abstract][Full Text] [Related]
11. Oligonucleotide microarrays with horseradish peroxidase-based detection for the identification of extended-spectrum β-lactamases. Rubtsova MY; Ulyashova MM; Edelstein MV; Egorov AM Biosens Bioelectron; 2010 Dec; 26(4):1252-60. PubMed ID: 20643540 [TBL] [Abstract][Full Text] [Related]
12. The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae. Doi A; Shimada T; Harada S; Iwata K; Kamiya T Int J Infect Dis; 2013 Mar; 17(3):e159-63. PubMed ID: 23140947 [TBL] [Abstract][Full Text] [Related]
13. Extended-spectrum beta-lactamases in North America, 1987-2006. Bush K Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():134-43. PubMed ID: 18154537 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Cantón R; Novais A; Valverde A; Machado E; Peixe L; Baquero F; Coque TM Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():144-53. PubMed ID: 18154538 [TBL] [Abstract][Full Text] [Related]
15. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Rupp ME; Fey PD Drugs; 2003; 63(4):353-65. PubMed ID: 12558458 [TBL] [Abstract][Full Text] [Related]
16. The continuing challenge of ESBLs. Perez F; Endimiani A; Hujer KM; Bonomo RA Curr Opin Pharmacol; 2007 Oct; 7(5):459-69. PubMed ID: 17875405 [TBL] [Abstract][Full Text] [Related]
17. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. Garau J Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548 [TBL] [Abstract][Full Text] [Related]
18. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines. Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398 [TBL] [Abstract][Full Text] [Related]
19. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. Dallenne C; Da Costa A; Decré D; Favier C; Arlet G J Antimicrob Chemother; 2010 Mar; 65(3):490-5. PubMed ID: 20071363 [TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis. Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]